Life ScienceCompany
PCI Synthesis Ownership
Who owns PCI Synthesis?
PCI Synthesis is owned by Seqens SAS. It was acquired on June 20, 2018.
PCI Synthesis Business Overview
Where is PCI Synthesis headquartered?
PCI Synthesis is headquartered in Newburyport, Massachusetts.
What sector is PCI Synthesis in?
PCI Synthesis is a life science company.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 249 acquisitions of life science companies in 2018, including 45 acquisitions by private equity firms, and 204 by strategics.